The Fly | VTRS

Global Scale and Market Reach: Viatris possesses an extensive global commercial and manufacturing footprint, enabling broad access to markets and significant economies of scale in production and distribution.

Diversified Product Portfolio: The company offers a broad array of products across various therapeutic areas, including established brands, complex generics, biosimilars, and over-the-counter medicines, reducing reliance on any single product line.

Robust Manufacturing and Supply Chain: With a strong, vertically integrated manufacturing network and significant supply chain expertise, Viatris maintains control over quality, cost, and ensures product supply reliability worldwide.

Intense Generic Competition and Pricing Pressure: Viatris operates in highly competitive markets, particularly for generic and off-patent branded drugs, leading to continuous pricing pressure and potential erosion of market share and profitability from new generic entrants and aggressive competitor pricing.

Strict Regulatory Scrutiny and Compliance: As a global pharmaceutical company, Viatris is subject to extensive and complex regulations from health authorities worldwide, including drug approval processes, manufacturing standards (GMP), adverse event reporting, and marketing practices, with non-compliance potentially leading to significant fines, product recalls, or market withdrawal.

Global Supply Chain Disruptions: Viatris's extensive global manufacturing and supply chain network is vulnerable to disruptions from various factors such as geopolitical events, natural disasters, trade policy changes, raw material shortages, and transportation issues, which could impact production, timely delivery of products, and ultimately revenue.